These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8877532)

  • 1. Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 beta-lactamase produced by Proteus mirabilis strains.
    Bret L; Chanal C; Sirot D; Labia R; Sirot J
    J Antimicrob Chemother; 1996 Aug; 38(2):183-91. PubMed ID: 8877532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3.
    Neuwirth C; Madec S; Siebor E; Pechinot A; Duez JM; Pruneaux M; Fouchereau-Peron M; Kazmierczak A; Labia R
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3591-4. PubMed ID: 11709345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic and structural properties of IRT-21 beta-lactamase (TEM-77) from a co-amoxiclav-resistant Proteus mirabilis isolate.
    Mammeri H; Gilly L; Laurans G; Vedel G; Eb F; Paul G
    FEMS Microbiol Lett; 2001 Dec; 205(2):185-9. PubMed ID: 11750800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of TEM mutants in Proteus mirabilis.
    Bonnet R; De Champs C; Sirot D; Chanal C; Labia R; Sirot J
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2671-7. PubMed ID: 10543745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of beta-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital.
    Chanal C; Bonnet R; De Champs C; Sirot D; Labia R; Sirot J
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1930-5. PubMed ID: 10858357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEM-72, a new extended-spectrum beta-lactamase detected in Proteus mirabilis and Morganella morganii in Italy.
    Perilli M; Segatore B; de Massis MR; Riccio ML; Bianchi C; Zollo A; Rossolini GM; Amicosante G
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2537-9. PubMed ID: 10952610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging extended-spectrum beta-lactamases in Proteus mirabilis.
    Pagani L; Migliavacca R; Pallecchi L; Matti C; Giacobone E; Amicosante G; Romero E; Rossolini GM
    J Clin Microbiol; 2002 Apr; 40(4):1549-52. PubMed ID: 11923394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TEM-187, a new extended-spectrum β-lactamase with weak activity in a Proteus mirabilis clinical strain.
    Corvec S; Beyrouthy R; Crémet L; Aubin GG; Robin F; Bonnet R; Reynaud A
    Antimicrob Agents Chemother; 2013 May; 57(5):2410-2. PubMed ID: 23478954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First description of DHA-1 ampCbeta-lactamase in Proteus mirabilis.
    Bidet P; Verdet C; Gautier V; Bingen E; Arlet G
    Clin Microbiol Infect; 2005 Jul; 11(7):591-2. PubMed ID: 15966982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a new extended-spectrum beta-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian survey.
    Perilli M; Segatore B; De Massis MR; Franceschini N; Bianchi C; Rossolini GM; Amicosante G
    Antimicrob Agents Chemother; 2002 Mar; 46(3):925-8. PubMed ID: 11850290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of Proteus mirabilis isolates producing TEM-52 extended-spectrum beta-lactamases in Croatia.
    Sardelić S; Bedenić B; Sijak D; Colinon C; Kalenić S
    Chemotherapy; 2010; 56(3):208-13. PubMed ID: 20551637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-lactamases produced by amoxicillin-clavulanate-resistant enterobacteria isolated in Buenos Aires, Argentina: a new blaTEM gene.
    Di Conza JA; Badaracco A; Ayala J; Rodríguez C; Famiglietti A; Gutkind GO
    Rev Argent Microbiol; 2014; 46(3):210-7. PubMed ID: 25444130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamases.
    Aragón LM; Mirelis B; Miró E; Mata C; Gómez L; Rivera A; Coll P; Navarro F
    J Antimicrob Chemother; 2008 May; 61(5):1029-32. PubMed ID: 18292096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first detection of CTX-M-14 extended-spectrum beta-lactamase among diverse beta-lactamase-producing Proteus mirabilis clinical isolates.
    Yong D; Lim YS; Roh KH; Choi YS; Park DY; Yum JH; Kim JM; Lee K; Chong Y
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):237-9. PubMed ID: 16427241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New TEM variant (TEM-92) produced by Proteus mirabilis and Providencia stuartii isolates.
    de Champs C; Monne C; Bonnet R; Sougakoff W; Sirot D; Chanal C; Sirot J
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1278-80. PubMed ID: 11257046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of CTX-M-140, a Variant of CTX-M-14 Extended-Spectrum β-Lactamase with Decreased Cephalosporin Hydrolytic Activity, from Cephalosporin-Resistant Proteus mirabilis.
    Tian GB; Jiang YQ; Huang YM; Qin Y; Feng LQ; Zhang XF; Li HY; Zhong LL; Zeng KJ; Patil S; Xing Y; Huang X
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6121-6. PubMed ID: 27480855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleotide sequences of the genes coding for the TEM-like beta-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2).
    Belaaouaj A; Lapoumeroulie C; Caniça MM; Vedel G; Névot P; Krishnamoorthy R; Paul G
    FEMS Microbiol Lett; 1994 Jul; 120(1-2):75-80. PubMed ID: 8056297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to beta-lactamase inhibitors.
    Brun T; Péduzzi J; Caniça MM; Paul G; Névot P; Barthélémy M; Labia R
    FEMS Microbiol Lett; 1994 Jul; 120(1-2):111-7. PubMed ID: 8056282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of a transposon Tn1-encoded inhibitor-resistant beta-lactamase gene, bla(TEM-67) from Proteus mirabilis, into the Escherichia coli chromosome.
    Naas T; Zerbib M; Girlich D; Nordmann P
    Antimicrob Agents Chemother; 2003 Jan; 47(1):19-26. PubMed ID: 12499163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic characterization of TEM-63, a TEM-type extended spectrum beta-lactamase expressed in three different genera of Enterobacteriaceae from South Africa.
    Hanson ND; Smith Moland E; Pitout JD
    Diagn Microbiol Infect Dis; 2001 Aug; 40(4):199-201. PubMed ID: 11576794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.